6505--Contingency Compounded Sterile Products Service

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

256-NETWORK CONTRACT OFFICE 16 (36C256)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C25626Q0014

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The procurement activity titled "Contingency Compounded Sterile Products Service" represents an award notice issued by the 256-Network Contract Office 16, a federal office operating under the organization key 100186525. This notice, identified by procurement number 36C25626Q0014, pertains to the acquisition of specialized pharmaceutical services, specifically the provision of compounded sterile products on a contingency basis. The scope of this procurement falls under NAICS Code 325412, which is defined as Pharmaceutical Preparation Manufacturing (2022 version). The associated Product Service Code is 6505, further indicating a focus on pharmaceutical products. The intended outcome of this contract is to ensure the availability of compounded sterile pharmaceutical preparations, likely to support healthcare operations in scenarios where standard supply chains may be disrupted or insufficient. Key requirements for this service would typically include the ability to manufacture, compound, and deliver sterile pharmaceutical products in compliance with federal regulations and industry standards. While the notice does not specify detailed deliverables, contractors can expect that the scope would encompass the timely and reliable provision of sterile preparations, adherence to quality and safety protocols, and responsiveness to contingency needs as directed by the contracting entity. The contracting office responsible for this award is located within the federal network, and the primary point of contact for inquiries is Tammie Chaney, who can be reached via email at [email protected] or by phone at 601-362-4471 ext 56372. The notice was posted on October 31, 2025, and is currently marked as inactive, indicating that the award process has concluded or the opportunity is no longer open for new submissions. This procurement is classified as an award notice, and there is no information provided regarding set-aside requirements or special considerations such as small business preferences or socioeconomic program participation. Contractors interested in similar future opportunities should note the classification codes and the nature of the services sought, as these elements are likely to remain consistent throughout the contract lifecycle. For further details, including any available attachments, interested parties may refer to the official notice on SAM.gov using Opportunity ID eeee4aa1b8794a4bbdd51112ce858022. In summary, this award notice reflects the federal government's commitment to maintaining contingency capabilities in pharmaceutical preparation manufacturing, with a focus on sterile compounded products. Contractors with expertise in this area may find alignment with the requirements and objectives outlined, particularly those capable of meeting rigorous quality and regulatory standards in a contingency context.